Position in ARVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$697,416
+$100,032 QoQ
Shares Held
83,925
+48.9% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. ARVN ranks #137 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $697,416 | 83,925 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $597,384 | 56,357 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,997,306 | 168,407 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,448,134 | 169,969 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,625,329 | 220,833 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $981,879 | 139,869 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $3,355,114 | 175,019 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $2,997,446 | 121,699 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,083,833 | 40,715 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,289,966 | 55,474 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $3,441,840 | 83,621 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $663,773 | 33,797 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $659,442 | 26,569 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $938,196 | 34,341 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $793,089 | 23,183 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $1,636,163 | 36,776 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $875,093 | 20,791 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,000,765 | 222,894 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $25,530,836 | 310,821 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $24,833,890 | 302,189 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $18,747,806 | 243,478 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $18,020,974 | 272,632 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $21,219,335 | 249,845 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,057,897 | 171,872 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,264,744 | 127,154 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,556,394 | 88,248 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||